PT - JOURNAL ARTICLE AU - Naohiro Yoshida AU - Hisashi Doyama AU - Tomonori Yano AU - Takahiro Horimatsu AU - Noriya Uedo AU - Yoshinobu Yamamoto AU - Naomi Kakushima AU - Hiromitsu Kanzaki AU - Shinichiro Hori AU - Kenshi Yao AU - Ichiro Oda AU - Chikatoshi Katada AU - Chizu Yokoi AU - Ken Ohata AU - Kenichi Yoshimura AU - Hideki Ishikawa AU - Manabu Muto TI - Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging AID - 10.1136/gutjnl-2019-319631 DP - 2021 Jan 01 TA - Gut PG - 67--75 VI - 70 IP - 1 4099 - http://gut.bmj.com/content/70/1/67.short 4100 - http://gut.bmj.com/content/70/1/67.full SO - Gut2021 Jan 01; 70 AB - Objective Early detection of gastric cancer has been the topic of major efforts in high prevalence areas. Whether advanced imaging methods, such as second-generation narrow band imaging (2G-NBI) can improve early detection, is unknown.Design This open-label, randomised, controlled tandem trial was conducted in 13 hospitals. Patients at increased risk for gastric cancer were randomly assigned to primary white light imaging (WLI) followed by secondary 2G-NBI (WLI group: n=2258) and primary 2G-NBI followed by secondary WLI (2G-NBI group: n=2265) performed by the same examiner. Suspected early gastric cancer (EGC) lesions in both groups were biopsied. Primary endpoint was the rate of EGC patients in the primary examination. The main secondary endpoint was the positive predictive value (PPV) for EGC in suspicious lesions detected (primary examination).Results EGCs were found in 44 (1.9%) and 53 (2.3%; p=0.412) patients in the WLI and 2G-NBI groups, respectively, during primary EGD. In a post hoc analysis, the overall rate of lesions detected at the second examination was 25% (n=36/145), with no significant differences between groups. PPV for EGC in suspicious lesions was 13.5% and 20.9% in the WLI (50/371 target lesions) and 2G-NBI groups (59/282 target lesions), respectively (p=0.015).Conclusion The overall sensitivity of primary endoscopy for the detection of EGC in high-risk patients was only 75% and should be improved. 2G-NBI did not increase EGC detection rate over conventional WLI. The impact of a slightly better PPV of 2G-NBI has to be evaluated further.Trial registration number UMIN000014503.